4.3 Article

2,4-O-Diacetylquercitrin, a Novel Advanced Glycation End-Product Formation and Aldose Reductase Inhibitor from Melastoma sanguineum

期刊

CHEMICAL & PHARMACEUTICAL BULLETIN
卷 61, 期 6, 页码 662-665

出版社

PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/cpb.c12-00877

关键词

Melastonia sanguineum; flavonoid; advanced glycation end-product; rat lens aldose reductase

资金

  1. Korea Institute of Oriental Medicine (KIOM) [K11040, K12040]
  2. National Research Council of Science & Technology (NST), Republic of Korea [K11040] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

A new flavonoid, 2,'' 4 ''-O-diacetylquercitrin (1), along with six known flavonoids (2-7) were isolated from the aerial parts of Melastoma sanguineunz. The structure of the new flavonoid was established by extensive spectroscopic studies and chemical evidence. The inhibitory effects of isolated compounds (1-7) on advanced glycation end-products (AGEs) formation and rat lens aldose reductase (RLAR) in vitro were examined. Of the tested compounds, compound 1 was the strongest inhibitor of AGEs, with an IC50 of 11.46 +/- 0.44 mu m. In the RLAR assay, all tested compounds exhibited greater inhibitory effects on RLAR than that of a positive control, 3,3-tetramethyleneglutaric acid (10(50)=28.8 +/- 1.5 mu m); compound 1 exhibited the strongest RLAR-inhibitory activity, with an IC50 of 0.077 +/- 0.003 mu m.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据